In contrast, patients with the Down syndrome (trisomy 21) are prone to cellular selection of acquired somatic GATA-1 mutations that produce GATA-1s and result in preleukemic myeloproliferative disorders [24]. The gene discussed is GATA1; the disease is Down syndrome.